Dedicated autism researchers are trying to develop animal models that allow for a better understanding of autism and may some day lead to better drugs to the disease. Rodent models of autism, while useful, have their limitations, and finding good models can be a challenge. So how does one find a good model for autism?
Simvastatin appears to disrupt sleep patterns of some patients.
Researchers identify an enzyme thought to be an important instigator of the inner-body conflict that causes Type 1 diabetes.
A drug used to treat high blood pressure and enlargement of the prostate may protect the brain from damage caused by post-traumatic stress disorder, Alzheimer's disease, depression and schizophrenia.
Phenocopy sometimes muddies up the genetic factors of disease risk, but a new way of looking at this issue soon might clean it up.
Advances in reporter gene technology aid the investigation of cellular activity. This has led to an increased number of options available to researchers.
Cell culture technology evolves from Ross Harrison's experiment.
LIMS may help with obstacles related to medium- and high-throughput ADME screening.
Hiring a Contract Research Organization can expedite the drug development process.
Asian lands experiencing up-and-downs in the biosciences continue to push forward to compete with the EU and US.
Merck’s food intake model aids high-throughput screening of anti-obesity drugs.
Drug manufacturers, law-makers, and consumer groups all found much to praise in the passage of the Food and Drug Administration Amendments Act of 2007 (HR 3580), which President Bush signed into law in late September. But much will depend on how the FDA implements the roughly 200 provisions contained in the 156-page piece of legislation.
With all of the cells in organisms, and cells just wandering around in the environment, scientists always seek new ways to sort them. The results unveil basic and applied value.
A group of companies that specialize in cardiac safety testing have joined forces to create a comprehensive and technologically advanced solution for determining how drugs affect the heart.
Metastatix announced that the US Food and Drug Administration has accepted its Investigational New Drug application for MSX-122.